Philadelphia, PA— Live from EFP ‘18: Bharat Tewarie, EVP & Chief Marketing Officer at UCB, shared his perspective on AI’s evolving role in pharma. Value in healthcare is opening doors for the healthcare team of the future…it’s patients + doctors + machines (Accenture, 2017):
- 75% of US consumers say technology is important to managing their health
- 19% of US consumers have used health services that are powered by AI—such as virtual clinicians and home-based diagnostics
He shared countless examples of Artificial Intelligence breaking into spaces across healthcare, including:
Disease detection and prediction:
IBM researchers use AI to predict risk of developing psychosis
Google AI predict heart disease by looking at your eyes
Identifying Treatment options:
UCB + Georgia Tech use AI to transform the future of Veterans’ treatment
Drug R&D:
DeepMind is revolutionizing drug discovery through AI
Why This Matters—
In light of the excitement surrounding these examples, it’s crucial to note that harnessing AI requires pharma to attract, augment and re-skill talent for the future. Currently the industry is facing an AI talent shortfall. Bharat shared that there are currently 300k AI researchers and practitioners worldwide, but the near-term market is in the millions of roles. Additionally, many of these AI experts sit clustered in just a few organizations—56% of today’s AI experts work in just 6 companies. We’re on the precipice of a shortage of AI experts in all fields. We need to reimagine and reinvent the role of “man and machine” in delivering value to patients.
